Skip to main content

Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703.

Publication ,  Conference
Wieduwilt, MJ; Yin, J; Kour, O; Teske, R; Stock, W; Byrd, K; Doucette, K; Mangan, J; Masters, GA; Mims, AS; Jamieson, K; Dinner, SN; Uy, GL ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
2023

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2023

Volume

41

Issue

16

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wieduwilt, M. J., Yin, J., Kour, O., Teske, R., Stock, W., Byrd, K., … Stone, R. M. (2023). Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).
Wieduwilt, Matthew Joseph, Jun Yin, Oudom Kour, Rebecca Teske, Wendy Stock, Kenneth Byrd, Kimberley Doucette, et al. “Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.
Wieduwilt MJ, Yin J, Kour O, Teske R, Stock W, Byrd K, Doucette K, Mangan J, Masters GA, Mims AS, Jamieson K, Dinner SN, Bseiso AW, Uy GL, Erba HP, Litzow MR, Stone RM. Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703. JOURNAL OF CLINICAL ONCOLOGY. 2023.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2023

Volume

41

Issue

16

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences